You are here:
PPCPS IN THE ENVIRONMENT: FUTURE RESEARCH - BEGINNING WITH THE END ALWAYS IN MIND
Citation:
Daughton, C G. PPCPS IN THE ENVIRONMENT: FUTURE RESEARCH - BEGINNING WITH THE END ALWAYS IN MIND. 2nd, Chapter 33, Dr. Klaus Kuemmerer (ed.), Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks. Springer Publishers, New York, NY, 33:463-495, (2004).
Impact/Purpose:
The research focused on in the subtasks is the development and application of state-of the-art technologies to meet the needs of the public, Office of Water, and ORD in the area of Water Quality. Located In the subtasks are the various research projects being performed in support of this Task and more in-depth coverage of each project. Briefly, each project's objective is stated below.
Subtask 1: To integrate state-of-the-art technologies (polar organic chemical integrative samplers, advanced solid-phase extraction methodologies with liquid chromatography/electrospray/mass spectrometry) and apply them to studying the sources and fate of a select list of PPCPs. Application and improvement of analytical methodologies that can detect non-volatile, polar, water-soluble pharmaceuticals in source waters at levels that could be environmentally significant (at concentrations less than parts per billion, ppb). IAG with USGS ends in FY05. APM 20 due in FY05.
Subtask 2: Coordination of interagency research and public outreach activities for PPCPs. Participate on NSTC Health and Environment subcommittee working group on PPCPs. Web site maintenance and expansion, invited technical presentations, invited articles for peer-reviewed journals, interviews for media, responding to public inquiries.
Subtask 3: To apply state-of-the-art environmental forensic techniques to the recognition and characterization of emerging pollutants in the aquatic environment. There is a need for high sensitivity and for a powerful method of structural characterization, advanced mass spectrometric and chromatographic techniques to be employed to meet the challenge of emerging pollutants, including pharmaceuticals and personal care products, agents of sabotage, and explosives. Ongoing efforts continue to identify previously unrecognized pollutants from a range of problematic samples having importance to regional and state contacts.
Subtask 4: To provide the Agency with a set of practical analytical methods for the selective and sensitive determination of selenium species (organic, inorganic, volatile and non volatile forms) in multiple media to accurately assess and if necessary control the risk of selenium exposure to organisms. This includes development of optimal extraction, digestion, separation and detection approaches.
Subtask 5: To develop and apply an analytical method that can extract and detect synthetic musks. The extent of exposure may be determined by measuring levels of synthetic musks from their potential source (communal sewage effluent). This subtask ends in FY05 with the deliverable of APM 21. Future applications to biosolids will be covered in subtask 6.
Subtask 6: Application, and improvement, of previously in-house developed sensitive, robust, and green, methodologies regarding the use of urobilin and sterols as a possible markers of sewage contamination.
Subtask 7: Adaptation and improvement of previously developed in-house methods, for PPCPs (e.g., antibiotics and musks) to solid materials (e.g. biosolids, sediments).
Subtask 8: Study of the presence of personal care products, incombustible organic compounds from the direct-piping of small engines exhaust in Lake Tahoe, and lake deposition of airborne pollutants from industrial activity
Description:
Pharmaceuticals and personal care products (PPCPs) are an extraordinarily diverse group of chemicals used in veterinary medicine, agricultural practice, and human health and cosmetic care. The various sources and origins of PPCPs as pollutants in the environment are depicted in an illustration (available: http://www.gov/nerlesd1/chemistrv/pharma/images/drawing.pdf; note: all the URLs cited in the text are from the web site Daughton/EPA 2003a).PPCPs are ubiquitous pollutants, owing their origins in the environment to their worldwide, universal, frequent, and highly dispersed but cumulative usage by multitudes of individuals (and domestic animals) and from other uses such as pest control(e.g.,see: http://www.epa.gov/nerlesd1/chemistry/phara/images/double-drugs.pdf). Therapeutic drugs in current use comprise over 3,000 distinct bioactive chemical entities formulated (using a wide array of so-called inert "excipients") into tens of thousands of registered end-use products. Personal care products contribute untold numbers of additional ingredients and formulations. Research, which began in earnest in the 1980s and has escalated dramatically in the early 2000s, was largely driven by analytical chemists and tended to focus on establishing the occurrence (and sources) of PPCPs in the environment -primarily in the aquatic domain (as a result of sewage discharge to receiving waters) and much less so in the terrestrial environment (as a result of land application of biosolids; U.S. EP A 2003). Only more recently has emphasis begun to shift to defining fate and transport, to assessing the effectiveness of and means of improving source control ( e.g., sewage treatment), and to pollution prevention.